Bucheon St. Mary's Hospital
Bucheon St. Mary's Hospital
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-04-28 | NCT06350617 | |
| Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-04-24 | NCT06270238 | |
| Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia | Deglutition Disorders, Digestive System Diseases, Pharyngeal Diseases, digestive system disorder, esophageal disorder, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-04-09 | NCT06305949 | |
| AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-03-24 | NCT07491029 | |
| SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study | Infarction, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, ischemic disease, metabolic disease, myocardial infarction, myocardial ischemia, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2025-01-03 | NCT05770687 | |
| Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2024-07-03 | NCT06138769 | |
| Severe Sepsis and Septic Shock Registry | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2023-11-24 | NCT02936232 |